Stock Code: 002923
Stock Abbreviation: Rundu Shares
Announcement No.: 2026-044
Zhuhai Rundu Pharmaceutical Co., Ltd.
Announcement on Olmesartan Medoxomil API Obtaining CEP Certificate
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or significant omissions.
Recently, Zhuhai Rundu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received a Certificate of Suitability to the Monograph of the European Pharmacopoeia (hereinafter referred to as the "CEP Certificate") for its Olmesartan Medoxomil API, issued by the European Directorate for the Quality of Medicines & HealthCare (hereinafter referred to as "EDQM"). The relevant situation is hereby announced as follows: